Task: Answer the multiple-choice question.
Question: Which drug exhibits a -43.566% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCC(CO)NCc1ccc(OCC(=O)Nc2cccc(C(F)(F)F)c2)c(OC)c1
b.) Cc1nc(NC(=O)CSc2nnnn2C)sc1C
c.) COc1ccc(-c2nc(C=O)cs2)cc1
Answer: a. CCC(CO)NCc1ccc(OCC(=O)Nc2cccc(C(F)(F)F)c2)c(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CO)NCc1ccc(OCC(=O)Nc2cccc(C(F)(F)F)c2)c(OC)c1
CCC(CO)NCc1ccc(OCC(=O)Nc2cccc(C(F)(F)F)c2)c(OC)c1
2-[4-[(1-hydroxybutan-2-ylamino)methyl]-2-methoxyphenoxy]-N-[3-(trifluoromethyl)phenyl]acetamide